COI Pharmaceuticals
COI Pharmaceuticals is a San Diego-based venture-pharma entity founded in 2013, operating with 11-50 employees under an experienced biotech leadership team to develop or hold pharmaceutical assets for partnership or spin-out.
- Company typePrivate
- Founded2013
- HeadquartersSan Diego, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What COI Pharmaceuticals does
COI Pharmaceuticals, operating as COI Pharma, is a venture-pharma entity headquartered in San Diego, California, founded in 2013. The company operates with a small team of 11-50 employees and is structured as a private for-profit enterprise. The "venture-pharma" designation indicates the company functions as a pharmaceutical venture creation, asset-holding, or development platform rather than a vertically integrated commercial-stage drug developer — a structure typical of entities that identify, incubate, and progress therapeutic programs toward partnership, licensing, or spin-out outcomes.
The leadership team comprises experienced biotech operators. Kevin Kinsella serves as a founding partner; Jay Lichter holds the role of President and CEO; Sergio Duron is Chief Scientific Officer; and Sanford J. Madigan is Senior Vice President. This composition suggests COI Pharma relies on senior domain expertise to evaluate and advance pharmaceutical opportunities rather than scaling internal R&D headcount.
Public information about the company's pipeline, revenue model, partnerships, and product portfolio is severely limited. The corporate website contains only a cookie consent notice with no substantive disclosures, and no funding rounds, customer relationships, partnerships, regulatory milestones, or revenue figures are documented in the available source material. As a result, the company's current scale, capitalization, and commercial posture cannot be independently verified from public sources.
COI Pharmaceuticals firmographics
Firmographics- Name
- COI Pharmaceuticals
- Website
- https://coipharma.com
- Company type
- Private
- Founded year
- 2013
- Headcount range
- 11–50 employees
- Short description
- COI Pharmaceuticals is a San Diego-based venture-pharma entity founded in 2013, operating with 11-50 employees under an experienced biotech leadership team to develop or hold pharmaceutical assets for partnership or spin-out.
- Ownership category
- akta.pro rank
COI Pharmaceuticals industry classification
Industry- Product category
- Pharmaceuticals
- NAICS
- Pharmaceutical and Medicine Manufacturing (3254), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Pharmaceutical Preparations (2834), Industrial Organic Chemicals (2860)
- akta.pro primary industry
- CMC & Pharmaceutical Development (Formulation/Process/Analytical Development) (HLAIALAD)
- akta.pro secondary industries
- Small-Molecule API Process Development & Route Scouting (HLAGAHAA), GMP Scale-Up, Tech Transfer & Process Validation (PPQ) (HLAGAHAL), Ophthalmology Pharmaceuticals (HLAIAAAL)
Keywords
Where COI Pharmaceuticals is headquartered
LocationHeadquarters
- HQ city
- San Diego
- HQ country
- United States
- HQ region
- North America
Markets served
COI Pharmaceuticals business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Operations
COI Pharmaceuticals product offering
Product offeringCore offering
COI Pharmaceuticals is a venture-pharma company founded in 2013 and based in San Diego that develops pharmaceutical assets. The company operates as a small drug development entity (11-50 employees) focused on advancing therapeutic candidates through the pharmaceutical value chain.
Differentiator
Problem solved
Functional benefit
Products and services
- Pharmaceutical Drug Development Pipeline
Companies that use COI Pharmaceuticals
Customer profileIdeal customer profiles1 record
COI Pharmaceuticals technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
COI Pharmaceuticals partnerships and signals
Strategic signalRecent moves1 record
Expansion highlights1 record
COI Pharmaceuticals competitors and assessment
Company assessmentMarket position
Competitive moat2 records
Key risks5 records
Key highlights4 records
Customer concentration
COI Pharmaceuticals social profiles
Digital presenceCOI Pharmaceuticals financial estimates
Financial estimateRevenue estimate
Valuation estimate
COI Pharmaceuticals leadership team
Management profileNumber of profiles
Profiles4 records
COI Pharmaceuticals funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
COI Pharmaceuticals M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about COI Pharmaceuticals
What does COI Pharmaceuticals do?
COI Pharmaceuticals is a venture-pharma company founded in 2013 and based in San Diego that develops pharmaceutical assets. The company operates as a small drug development entity (11-50 employees) focused on advancing therapeutic candidates through the pharmaceutical value chain.
When was COI Pharmaceuticals founded?
COI Pharmaceuticals was founded in 2013. It employs 11 to 50 people.
Where is COI Pharmaceuticals based?
COI Pharmaceuticals is headquartered in San Diego, United States, in the North America region.
Does COI Pharmaceuticals have an API?
No public API is recorded for COI Pharmaceuticals.
What industry is COI Pharmaceuticals in?
COI Pharmaceuticals's product category is Pharmaceuticals. Its primary akta.pro industry code is HLAIALAD, CMC & Pharmaceutical Development (Formulation/Process/Analytical Development), with a secondary code of HLAGAHAA, Small-Molecule API Process Development & Route Scouting. Its NAICS code is 3254 and its SIC code is 2834.